Mark Pollack to Retrospective Studies
This is a "connection" page, showing publications Mark Pollack has written about Retrospective Studies.
Connection Strength
0.259
-
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255.
Score: 0.081
-
Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007 Jul; 68(7):1010-3.
Score: 0.039
-
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):255-64.
Score: 0.037
-
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11.
Score: 0.033
-
Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359.
Score: 0.020
-
Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7.
Score: 0.012
-
Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depress Anxiety. 2009; 26(11):1027-32.
Score: 0.011
-
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73.
Score: 0.008
-
Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001; 13(4):166-78.
Score: 0.006
-
History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord. 2000 May; 58(2):99-106.
Score: 0.006
-
Quantitative serum toxic screening in the management of suspected drug overdose. Am J Emerg Med. 1990 Jan; 8(1):16-22.
Score: 0.003
-
Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
Score: 0.003